A Systems-Level Analysis of Human Physiological Rhythms: Recommendations for a High-Fidelity, Mechanistic Simulation Model

Executive Summary

Objective: This report provides a comprehensive research analysis and a set of architectural recommendations to significantly improve an existing physiological simulation model. The analysis is predicated on a large corpus of technical and medical research.
Core Recommendation: The primary strategic recommendation is to transition the simulation's architecture from a descriptive, static-profile model (which likely replays pre-defined 24-hour hormone curves) to a dynamic, mechanistic, and predictive "system of systems." The physiological rhythms of the body should not be inputs to the model; they should be emergent properties of the model itself.
Methodology: This report analyzes and synthesizes a body of physiological research to extract three categories of actionable information required for this architectural upgrade:
1. Core Mathematical Frameworks: Identifies established, quantitative models for core physiological systems, such as limit-cycle oscillators for circadian pacemaking and pharmacodynamic (PD) models for hormonal dose-response.
2. Quantitative, Implementable Parameters: Extracts and tabulates specific quantitative data, including 24-hour signal profiles (peaks, nadirs, onsets), pharmacokinetic (PK) parameters (half-lives, clearance rates), and reaction constants (e.g., $V_{max}$, $K_m$).
3. Critical Inter-System Coupling Pathways: Defines the feedback and feedforward connections that link the neuro-endocrine, neuro-immune, and neuro-autonomic systems, allowing for the simulation of complex, multi-system responses.
Key Improvements: The proposed enhancements are structured in a hierarchical, three-tiered approach.
• Tier 1: Upgrades the core circadian (Suprachiasmatic Nucleus, SCN) and stress (Hypothalamic-Pituitary-Adrenal, HPA) axes with dynamic, state-of-the-art mathematical models.
• Tier 2: Implements critical modulatory systems, including the Orexin/Arousal and Histamine/Serotonin pathways, to create a functional "sleep-wake switch" and model state-dependent reactivity.
• Tier 3: Expands the simulation into the neuro-immune and peripheral metabolic subsystems, enabling the model to simulate advanced, holistic scenarios such as sickness behavior and circadian misalignment (e.g., shift work, social jet lag).
This tiered roadmap provides a long-term plan to evolve the simulation into a high-fidelity, predictive tool capable of modeling emergent physiological behaviors in response to dynamic environmental inputs.

Part I: The Central Pacemaker and Environmental Entrainment

The foundation of a high-fidelity physiological simulation rests on a robust, dynamic, and entrainable central pacemaker. This section details the necessary upgrades to the Suprachiasmatic Nucleus (SCN) model, its primary environmental input (light), and its most reliable
peripheral output (melatonin).

1.1 The Suprachmatic Nucleus (SCN) as a Heterogeneous, Coupled Oscillator Network

The central circadian pacemaker, located in the SCN of the hypothalamus, is the "master clock" that drives 24-hour rhythms in both physiology and behavior.1
A "significant improvement" to the simulation requires moving beyond a simplistic, single-oscillator representation. The research clearly indicates that the SCN's robust 24-hour rhythm is an emergent property of a multicellular network, not the property of a single "clock" cell. Individual SCN neurons, when cultured in isolation, exhibit "weak or unstable rhythms".5 Longitudinal rhythmicity is lost when these cells are separated.5 The coherent, self-sustaining rhythm of the SCN as a whole depends entirely on mutual synchronization among its constituent neurons.2
This network structure is what confers robustness to the pacemaker, allowing it to resist perturbations (e.g., from temperature) and provide stability to the entire organism's temporal architecture.6 Therefore, the simulation's architectural choice for the SCN is a critical decision point.
• Tier 1 (Insufficient): A single sine wave or pre-programmed 24-hour signal. This is static and cannot be entrained by environmental inputs.
• Tier 2 (Good): A single, self-sustained limit cycle oscillator model, such as a van der Pol oscillator.7 This mathematical construct can be "forced" or "entrained" by an external periodic signal (light), which is a major improvement.
• Tier 3 (High-Fidelity): A model of coupled damped oscillators.9 In this advanced topology, individual oscillators (neurons) are modeled as damped (i.e., not self-sustaining) and only produce a coherent, sustained rhythm when coupled together and receiving a periodic signal. This model correctly demonstrates that rhythmicity and synchrony are "codependent".9 This architecture allows the simulation to model critical real-world phenomena, such as dampened rhythm amplitude resulting from uncoupling or desynchrony from weak coupling signals.10
The intercellular signaling factors that mediate this network coupling are known. These include neuropeptides such as Vasoactive Intestinal Polypeptide (VIP) 11 and Arginine Vasopressin (AVP).12 AVP neurons, in particular, are suggested to "regulate the period of the circadian rhythm of the entire SCN" 12, making them a key component of the network's feedback dynamics.

1.2 Modeling Photic Entrainment: The Forger-Kronauer Framework

The SCN is entrained to the 24-hour solar day via photic signals from the retina.1 Light is the primary zeitgeber (time cue) that resets the biological clock daily.12 This entrainment process is nonlinear and has been extensively modeled.
The gold standard for mathematically modeling the human circadian pacemaker's response to light is the framework developed by Forger, Kronauer, and colleagues.14 A high-fidelity SCN model should be based on this framework.
A critical feature of this model is its two-component structure:
1. Process P (Pacemaker): This is the core circadian oscillator itself, often modeled as a two-variable (x, c) limit cycle oscillator.7
2. Process L (Light): This is not simply the raw light input. It is a dynamic process that models the adaptation of the system to light.17
This two-process architecture is a significant architectural enhancement. It means the effect of a light stimulus is dependent on the history of light exposure. This adaptation mechanism provides "robustness" and "refractoriness" to light perturbations, preventing the clock from being erroneously reset by brief flashes of light.18
The Forger-Kronauer model also incorporates a direct effect of light on the oscillator's intrinsic period ($\omega$), in accordance with "Aschoff's rule," which states that as light intensity increases, the circadian period decreases (in diurnal organisms).8 The model's primary output is its ability to generate a Phase Response Curve (PRC), which correctly predicts whether a light pulse at a specific circadian time will cause a phase advance, a phase delay, or have no effect.19 The model's ability to accurately predict these phase shifts is a key validation metric.21

1.3 The Melatonin Subsystem: An SCN-Driven Chronobiotic Signal

Melatonin is the primary neurohormone that signals "biological night" to the body.13 It is secreted by the pineal gland, which is under the direct control of the SCN.3 As such, its 24-hour profile is the "best peripheral index of the timing of the human circadian pacemaker".13
A critical architectural pattern emerges from the data: light has two distinct effects that must be modeled via two separate pathways.
1. SCN Entrainment (Slow): Light input drives the Forger-Kronauer model (Process L/P), which slowly shifts the phase of the central SCN oscillator to entrain it to the 24-hour day.15
2. Melatonin Suppression (Fast): Light acutely and directly suppresses melatonin secretion at night.1
The simulation must implement both pathways. The Light_Input signal must simultaneously be an input to the SCN oscillator model (pathway 1) and a direct, fast-acting inhibitory term on the melatonin production rate (pathway 2). This is the only way to accurately simulate the real-world phenomenon where turning on a bright light at 2 a.m. immediately halts melatonin production while also inducing a phase shift for the following day.
From a modeling perspective, the melatonin subsystem is a simple pharmacokinetic (PK) model:
$$d[Melatonin]/dt = Production(SCN(t), Light(t)) - Clearance$$

The Clearance term is first-order ($k \times [Melatonin]$). The research provides the necessary parameters. Melatonin is rapidly distributed (distribution $t_{1/2}$ of 0.5–5.6 minutes) 23 and rapidly eliminated (elimination $t_{1/2}$ of ~45–66 minutes).24 This fast clearance is precisely why melatonin is such an excellent real-time marker of SCN activity; its plasma level is a direct reflection of current production, not a slow-building accumulation.
The Production term is a function gated on by the SCN's "night" state and inhibited off by the Light_Input signal. The parameters for this production function can be set and validated against the quantitative 24-hour profile data. The most reliable phase marker is the Dim Light Melatonin Onset (DLMO), the time at which melatonin levels begin to rise.26 This should be a primary validation output of the simulation.
Table 1: Quantitative 24-Hour Profile and Pharmacokinetics of MelatoninParameterValueSource(s)NotesDim Light Melatonin Onset (DLMO)~21:18 $\pm$ 51 min26Most reliable phase marker. Calculated using "3k" threshold.Dim Light Melatonin Onset (DLMO)~21:48 $\pm$ 61 min26Calculated using fixed 3 pg/mL threshold.Plasma Rise Time (start)~21:2229Study with lights off at 22:00.Plasma Peak Time (Acrophase)~02:5529Peak concentration (74.91 pg/ml) in study subjects.Elimination Half-Life ($t_{1/2}$)45–66 min24For immediate-release oral or IV administration.Distribution Half-Life ($t_{1/2}$)0.5–5.6 min23After intravenous administration.

Part II: Modeling the Hypothalamic-Pituitary-Adrenal (HPA) Axis

The HPA axis is the body's primary neuroendocrine system for managing stress and coordinating metabolism.31 It is one of the most dynamic and well-quantified systems, offering a major opportunity for a high-fidelity, mechanistic upgrade.

2.1 A Mechanistic, Multi-Timescale Model of the HPA Cascade

The HPA axis is a three-organ cascade 31:
1. Hypothalamus (PVN): Secretes Corticotropin-Releasing Hormone (CRH) and Arginine Vasopressin (AVP).
2. Anterior Pituitary: CRH/AVP stimulate the secretion of Adrenocorticotropic Hormone (ACTH).
3. Adrenal Cortex: ACTH stimulates the synthesis and release of Glucocorticoids (primarily Cortisol in humans).
The system is controlled by a primary negative feedback loop: Cortisol, circulating in the blood, inhibits the synthesis and release of both CRH at the hypothalamus and ACTH at the pituitary.31
A high-fidelity HPA model must incorporate two distinct types of rhythmicity that are clearly identified in the research:
1. Circadian Rhythm (24-hour): The HPA axis is governed by a robust 24-hour rhythm, driven by the SCN.38 This rhythm manifests as a high-amplitude fluctuation in cortisol levels, with an acrophase (peak) in the early morning and a nadir (trough) around midnight.38 The SCN appears to modulate the sensitivity of the adrenal glands to ACTH, especially during the rising portion of the 24-hour rhythm.42
2. Ultradian Rhythm (Pulsatile): Superimposed on this 24-hour cycle is a much faster ultradian rhythm. Secretion of ACTH and cortisol is not continuous but occurs in pulses.38 These pulses have a period of approximately 60–90 minutes in humans 41 or 1–3 hours.43 This pulsatile dynamic is essential for normal HPA function and stress responsiveness.35
The simulation must model both. The 24-hour circadian rhythm (driven by the SCN model from Part I) provides a gating signal or setpoint modulation. The fast, ultradian rhythm is an emergent property of the HPA axis itself, likely generated by the time delays within the CRH-ACTH-Cortisol feedback loops.43
Furthermore, a key discrete event must be specifically modeled: the Cortisol Awakening Response (CAR). This is a sharp, substantial peak in cortisol that occurs 30–60 minutes after awakening from nocturnal sleep.40 This event is distinct from the overall circadian rise. It is an "abrupt elevation" 41 that likely plays a specific role in synchronizing the body to the sleep-wake transition.40 The model must simulate the CAR by linking the Sleep_State -> Wake state transition (from the sleep model) to a direct, large-amplitude pulse of CRH/ACTH, which is then superimposed on the already-rising circadian setpoint.
The following table provides the quantitative parameters necessary to build and validate the HPA axis differential equations.
Table 2: Quantitative 24-Hour Profile and Pharmacokinetics of HPA Axis HormonesHormoneParameterValueSource(s)NotesCortisolAcrophase (Peak)06:00–10:0042Other sources specify 07:00–08:00 45 or "at the moment the individual wakes up".40CortisolNadir (Trough)22:00–02:0042Quiescent period of minimal secretory activity.CortisolCortisol Awakening Response (CAR)Peak 30–60 min after awakening40A discrete event superimposed on the circadian peak.CortisolElimination Half-Life ($t_{1/2}$)~66 min (normal levels)46Nonlinear: increases to 120 min with large steroid loads.ACTHAcrophase/NadirFollows Cortisol35ACTH and Cortisol profiles are parallel.ACTHRelative Scalingis 4 orders of magnitude smaller than [Cortisol]47Critical scaling factor for model equations.CRHElimination Half-Life ($t_{1/2}$)~45 min48Pharmacokinetics of intravenously administered hCRF.

2.2 Quantifying HPA Dynamics: Dose-Response and Feedback

To make the HPA model truly mechanistic, the links in the cascade must be replaced with quantitative, nonlinear functions. The research provides data for the two most critical functions: the ACTH-Cortisol feedforward drive and the Cortisol-ACTH/CRH feedback loop.
Feedforward: The ACTH-Cortisol Dose-Response Relationship
The secretion of cortisol by the adrenal gland in response to ACTH is a nonlinear dose-response relationship.49 This relationship can be characterized by its efficacy (maximal secretion rate), sensitivity, and $EC_{50}$ (the concentration of ACTH that produces a half-maximal response).49
This type of sigmoidal relationship is mathematically described by a 4-parameter Hill function 51 or logistic function.54 The simulation should implement this as:
$$Cortisol\_Production\_Rate = V_{max\_circadian}(t) \times \frac{^n}{EC_{50}^n +^n}$$

Here, $n$ is the Hill coefficient (determining the steepness of the response). The circadian input from the SCN would modulate the $V_{max\_circadian}(t)$ term, effectively changing the adrenal gland's maximal output capacity throughout the day, consistent with the finding that the SCN increases adrenal sensitivity during its rising phase.42 Quantitative data is available for parameterization: one study in normal-weight women found the $V_{max}$ (efficacy) to be 26.3 nmol/l per minute.50 More advanced (Tier 3) implementations could also incorporate hysteresis, as the cortisol response to a given ACTH level differs for rising versus falling ACTH concentrations.55
Feedback: The Cortisol-ACTH/CRH Negative Feedback Relationship
The negative feedback of cortisol on the pituitary and hypothalamus is the most critical regulatory component of the HPA axis. A high-fidelity model must incorporate a crucial, non-obvious mechanism: the dual-receptor system.
Feedback is not mediated by a single function but by two distinct types of glucocorticoid receptors, which have different affinities for cortisol 37:
1. Mineralocorticoid Receptors (MR): These are high-affinity receptors. They are "substantially occupied" by cortisol even at the low concentrations seen during the circadian nadir.37 Their function is to maintain the basal set point of the HPA axis.37
2. Glucocorticoid Receptors (GR): These are lower-affinity receptors. They are not significantly activated by low basal cortisol levels. They become occupied during the circadian peak and, most importantly, during a stress response.37 Their function is to mediate the strong negative feedback that terminates the stress response and brings cortisol levels back down.37
This dual-receptor system is a fundamental principle of HPA homeostasis.56 Some models even suggest MRs may exert a positive feedback to stabilize the system, while GRs provide the negative feedback.34
This is a massive architectural improvement for the simulation. The model must simulate two feedback pathways. The [Cortisol] state variable would bind to and state variables with different affinity constants ($K_m$). The signal would then regulate the basal *setpoint* of CRH/ACTH production, while the signal would provide the strong, inhibitory feedback on CRH_Production_Rate and ACTH_Production_Rate. This dual-system architecture is the only way to model a system that is both stable at baseline and capable of rapid, high-amplitude stress responses followed by efficient termination.

Part III: Modulatory Systems and State-Dependent Coupling

The core circadian and HPA axes do not operate in a vacuum. Their activity is heavily modulated by the organism's behavioral state, primarily the sleep-wake cycle. This section details the modeling of the Orexin/Arousal system, which forms the critical bridge between sleep state and neuroendocrine function.

3.1 The Orexin/Arousal System: Modeling Neuronal Activity

Orexin (also known as hypocretin) is a neuropeptide that is a primary driver of wakefulness and arousal.4 Its dysfunction is the cause of narcolepsy.
An analysis of the research reveals a critical, apparent contradiction that presents a classic pitfall for modelers.
• The Pitfall: Research on plasma orexin-A (OXA) levels in humans concludes that "plasma OXA levels do not undergo a circadian rhythm".29
• The Resolution: Research on the neuronal discharge rate of orexin neurons in the hypothalamus shows a completely different story. The firing rate of these neurons is highly rhythmic, but it is locked to the sleep-wake state, not the 24-hour circadian cycle.58
Specifically, the neuronal discharge profile is:
• High Firing Rate: During active waking.
• Decreased Firing Rate: Decreases approximately 6-fold during quiet wakefulness.
• Virtually Silent: During Slow Wave Sleep (SWS), REM sleep, and the transitions between these states.58
The modeling implication is profound: the functional signal to be simulated is the orexin neuronal firing rate, not the misleading plasma concentration. The simulation must include a Sleep_State variable (e.g., Awake, SWS, REM), and the Orexin_Activity signal must be a function of this state, as described by the data.58
With a functional Orexin_Activity signal, its critical couplings to the HPA axis can be implemented. Orexin is a potent activator of the HPA axis, forming the "arousal-stress link".59
• Mechanism: Orexin neurons project to the PVN and "activate CRH neurons".62 This activation occurs "predominantly at the hypothalamic level" 64 and targets OX2R receptors on these CRH-positive neurons.64 The interaction is known to be reciprocal.65
• Implementation: This is a key feedforward coupling. The Orexin_Activity signal must be a positive input to the CRH_Production_Rate equation derived in Part II.
$$CRH\_Production\_Rate += k_{orexin} \times [Orexin\_Activity]$$

This pathway mechanistically models why arousal and wakefulness (high orexin) are associated with a higher, more reactive HPA tone, and why chronic stress (which activates the HPA) often leads to hyper-arousal and insomnia (via the reciprocal HPA->Orexin link).

3.2 Secondary Couplings: Serotonin and Histamine

To further enhance the model's fidelity, especially in its simulation of sleep-wake transitions and mood-stress interactions, secondary modulatory pathways can be implemented.
Histamine:
Histamine is a "key wake-promoting neurotransmitter".66 It acts in opposition to the sleep-promoting signal of melatonin. The research explicitly notes the "interdependence between melatonin and histamine" 66 and their combined role in modulating circadian rhythms. This suggests a "sleep-wake switch" architecture. A new state variable, Histamine_Activity, can be implemented. This variable would be inhibited by the [Melatonin] signal (consistent with melatonin's sleep-promoting effects 68) and would, in turn, act (along with Orexin_Activity) as a positive drive on the "Wake" state.
Serotonin:
Serotonin (5-HT) is fundamentally linked to mood, stress vulnerability, and HPA function.69 The data provides a specific, high-fidelity link: 5-HT4 receptor binding is "associated with the cortisol awakening response".71 This provides a more nuanced mechanism for the CAR. The amplitude of the CAR "pulse" (modeled in Section 2.1) should not be a fixed constant. Instead, it can be modulated by a Serotonin_Tone state variable.
$$CAR\_Pulse\_Amplitude = f()$$

This Tier 2 enhancement would allow the model to simulate how factors that alter serotonergic tone (e.g., chronic stress, genetic factors, antidepressant medications) can "blunt" or "enhance" the CAR, a key biomarker in clinical depression.69

Part IV: The Neuro-Immune-Autonomic Frontier: Expanding Model Fidelity

The most significant improvement to the simulation, elevating it to a truly holistic, next-generation model, is the incorporation of the neuro-immune and peripheral metabolic systems. This transforms the model from a simulation of isolated neuroendocrine axes into an integrated "system of systems."

4.1 The Neuro-Immune Interface: Bidirectional Cytokine Loops

The immune, endocrine, and nervous systems are not separate; they are engaged in constant, bidirectional communication.72 This "neuro-immune-endocrine network" 76 is critical for homeostasis. The HPA axis (stress hormones) is a well-known suppressor of the immune system.73 Reciprocally, immune mediators (cytokines) "play an important role in neural physiology" and can "shape synaptic plasticity".75
A Tier 3 enhancement would be to add state variables for key pro-inflammatory cytokines, which themselves are under circadian control.
• Interleukin-6 (IL-6): IL-6 exhibits a robust circadian rhythm.77 This rhythm has been described as having a single nocturnal peak (acrophase ~02:16) 78 or as being biphasic in plasma (peaks ~16:00 and ~04:00).79 IL-6 is also linked to the homeostatic drive for sleep and sleepiness.77
• Tumor Necrosis Factor-alpha (TNF-alpha): TNF-$\alpha$ also shows circadian oscillation and is involved in the regulation of the core clock genes themselves.81
Adding [IL6] and `` as state variables, with their own circadian-driven production rates (gated by the SCN) and clearance terms, enables the simulation of a complex, emergent behavior: "sickness behavior."
The components for this loop have already been established in this report:
1. Cytokine -> Orexin: "Orexin suppression by elevated cytokines" is a known mechanism for fatigue.59
2. Orexin -> Wakefulness: Orexin neuronal activity is required to maintain wakefulness.58
3. HPA -> Cytokine: Stress hormones (cortisol) suppress the immune system and inflammation.73
4. Immune -> HPA: Immune signals can activate the HPA axis.74
This allows for the modeling of a complete feedback loop:
1. An "Infection" or "Inflammation" event is triggered in the simulation, driving [IL6] and `` production rates up.
2. The high [IL6] levels provide a strong inhibitory input to Orexin_Activity.59
3. The drop in Orexin_Activity causes a state transition from "Wake" to "Fatigue" or "Sleep" (this is the mechanism for the fatigue and "unrefreshing sleep" of sickness 59).
4. Simultaneously, the inflammatory signal acts as a stressor, activating the HPA axis (via immune-to-brain pathways 74).
5. The resulting increase in [Cortisol] provides the anti-inflammatory response, acting as a negative feedback signal to suppress the production of [IL6] and ``.73
This complete, closed-loop system (Inflammation $\rightarrow$ Fatigue $\rightarrow$ Stress Response $\rightarrow$ Anti-Inflammation) is a major, high-fidelity enhancement that allows the model to predict the dynamic time-course of an inflammatory response.

4.2 Peripheral Clocks and Metabolic Synchronization (Glucose/Insulin)

The SCN is the master clock, but it is not the only clock. Peripheral tissues, including the liver, muscle, and heart, contain their own cell-autonomous circadian clocks.3
These peripheral clocks are synchronized ("entrained") by the SCN's outputs—primarily cortisol (which functions as the main central synchronizing signal) 38 and melatonin.84 However, they are also strongly entrained by behavioral cues, most notably feeding time.84
Metabolic diseases like Type 2 Diabetes are increasingly linked to circadian disruption.86 This disruption is a misalignment between the central, SCN-driven light/dark clock and the peripheral, feeding-driven metabolic clocks.86
The simulation can be "significantly improved" by modeling this phenomenon. This involves adding a peripheral metabolic subsystem (e.g., Glucose/Insulin) and treating it as its own "peripheral clock" that is entrained by two separate "zeitgebers": the SCN (via cortisol) and a Meal_Time input. This architecture would allow the simulation to model "Social Jet Lag" or "Shift Work" by desynchronizing the Light_Input (SCN) and Meal_Time (peripheral) inputs, and the model would predict the resulting metabolic dysregulation.
The research provides a direct, quantitative, and well-established mathematical framework for the glucose/insulin system: Michaelis-Menten kinetics.
• Mechanism: Glucose uptake by tissues (e.g., muscle) is a facilitated transport process.88 The effect of insulin is to increase the $V_{max}$ (maximum velocity, or transport capacity) of this system. It does not significantly alter the $K_m$ (Michaelis constant, or substrate-transporter affinity).88
• Implementation: This translates directly into a set of equations:
$$Glucose\_Uptake\_Rate = V_{max\_eff} \times \frac{[Glucose]}{K_m + [Glucose]}$$$$V_{max\_eff} = V_{max\_basal} + V_{max\_insulin\_dependent}$$$$V_{max\_insulin\_dependent} = f([Insulin])$$
The function $f([Insulin])$ can be a simple linear relationship or a Hill function, and it can be parameterized directly from the data provided in the following table.
Table 3: Michaelis-Menten Kinetic Parameters for Insulin-Mediated Glucose UptakeParameterValueSource(s)Notes$K_m$ (Michaelis constant)~10–12 mM90The affinity of the transport system for glucose. This value remains stable.$V_{max}$ (at 0 insulin)~5.2 mg $\cdot$ kg⁻¹ $\cdot$ min⁻¹90Basal, non-insulin-mediated glucose uptake.$V_{max}$ (at ~80 $\mu$U/ml insulin)~18.5 mg $\cdot$ kg⁻¹ $\cdot$ min⁻¹90Insulin increases $V_{max}$ nearly 3-fold.$V_{max}$ (at ~160 $\mu$U/ml insulin)~26.8 mg $\cdot$ kg⁻¹ $\cdot$ min⁻¹90Insulin increases $V_{max}$ nearly 5-fold.

Part V: Synthesis, Validation, and Implementation Roadmap

This final section synthesizes all previous components into a unified architectural vision, outlines a strategy for model parameterization and validation, and provides a tiered, actionable implementation plan.

5.1 A Unified "System of Systems" Model Architecture

The ultimate goal is to create a single, unified simulation model. This model is best architected as a large system of coupled Ordinary Differential Equations (ODEs).84 This entire framework can be viewed as a large-scale, endogenous Pharmacokinetic/Pharmacodynamic (PK/PD) model.91 In this model, the "drugs" are endogenous hormones and neurotransmitters, and the "pharmacodynamic response" is the effect these signals have on the production or clearance rates of other signals.94
This "system of systems" can be visualized as a network:
• External Inputs (Zeitgebers):
    ◦ Light(t): Drives the SCN (slow) and suppresses Melatonin (fast).
    ◦ Meal_Time(t): Drives the peripheral metabolic (Glucose/Insulin) clock.
    ◦ Stressor_Event(t): Provides a direct, pulsatile input to CRH production.
    ◦ Infection_Event(t): Provides a direct input to Cytokine production.
• Core Oscillators:
    ◦ SCN (Circadian): A Forger-Kronauer limit-cycle oscillator 17 that generates the 24-hour master clock signal.
    ◦ HPA (Ultradian): A pulse generator that emerges from the CRH-ACTH-Cortisol feedback delays.43
• State Variables (include, but are not limited to):
    ◦ SCN_Phase, SCN_Amplitude
    ◦ [Melatonin]
    ◦ , , [Cortisol]
    ◦ [Orexin_Activity] (function of Sleep_State)
    ◦ [Histamine_Activity]
    ◦ [IL6], ``
    ◦ [Glucose], [Insulin]
• Key Coupling Links (as derived in this report):
    ◦ SCN $\rightarrow$ Melatonin_Production
    ◦ SCN $\rightarrow$ HPA_Circadian_Gain ($V_{max}$ or sensitivity) 42
    ◦ SCN $\rightarrow$ Cytokine_Circadian_Production 78
    ◦ Light $\dashv$ Melatonin_Production 13
    ◦ ACTH $\rightarrow$ Cortisol_Production (Hill Function) 50
    ◦ Cortisol $\dashv$ ACTH_Production (Dual MR/GR) 37
    ◦ Cortisol $\dashv$ CRH_Production (Dual MR/GR) 37
    ◦ Sleep_State $\rightarrow$ Orexin_Activity 58
    ◦ Orexin_Activity $\rightarrow$ CRH_Production 62
    ◦ Melatonin $\dashv$ Histamine_Activity 66
    ◦ Cytokines (IL6) $\dashv$ Orexin_Activity (Sickness/Fatigue) 59
    ◦ Cortisol $\dashv$ Cytokine_Production (Anti-inflammatory) 73
    ◦ Insulin $\rightarrow$ Glucose_Uptake_Vmax (Metabolism) 90

5.2 Parameterization and Validation Using Public Datasets

A model of this complexity must be rigorously parameterized and validated against real-world human data.95 Several public datasets are available for this purpose.
• MMASH (Multi-Modal-Activities-Sleep-Health) 96:
    ◦ Data: This dataset provides 24-hour time-series data for physiological signals (Heart Rate, Accelerometer) alongside crucial, but sparse, hormone data.96
    ◦ Validation Use: A key finding is that the MMASH dataset does not contain 24-hour hormone time-series. Rather, it provides saliva concentrations for cortisol and melatonin "before sleeping and immediately after waking up".96 This initially appears to be a limitation, but it is a significant opportunity. These two time points are perfect for validating the model's two most important discrete phase markers: the DLMO (which should correlate with the "before sleeping" melatonin sample) and the CAR (the "after waking" cortisol sample). The model's predicted DLMO and CAR values can be directly compared against this dataset for phase and amplitude validation.
• PhysioNet 97:
    ◦ Data: PhysioNet is a vast repository of high-frequency, time-series physiological data, including continuous glucose monitoring (CGM) 99, Heart Rate Variability (HRV) 98, and ECG.101
    ◦ Validation Use: This is the primary validation source for the peripheral subsystems. The simulation's [Glucose] state variable, when driven by a Meal_Time input, can be directly compared to the CGM time-series data from PhysioNet.99 Furthermore, the model's neuro-autonomic state (e.g., a state variable representing Sympathetic/Parasympathetic balance) can be used to drive a simple heart-rate generator, and the resulting synthetic HRV data can be statistically compared to the real HRV data in PhysioNet.100
• NHANES (National Health and Nutrition Examination Survey) 102:
    ◦ Data: NHANES provides large-scale, cross-sectional population data, including biomarker measurements for hormones.103
    ◦ Validation Use: While not useful for validating 24-hour dynamics, NHANES is essential for parameterizing the model's baseline and variability. The model's baseline parameters should be tuned so that its steady-state outputs (e.g., mean morning cortisol) match the population mean from NHANES. The variance reported in NHANES can then be used to define the parameter distributions for Monte Carlo simulations, allowing the model to simulate a virtual population.

5.3 Hierarchical Recommendations for Model Improvement

The following tiered roadmap provides a structured implementation plan, moving from core enhancements to frontier-level expansion.
Tier 1: Core Enhancement (The Dynamic Engine)
1. Replace Static Clocks: Decommission any static, pre-defined 24-hour signal curves.
2. Implement SCN: Implement the SCN as a dynamic oscillator using the Forger-Kronauer (or similar) limit-cycle framework, driven by a dynamic Light_Input variable.15
3. Implement HPA: Implement the HPA axis as a system of ODEs, incorporating both the 24-hour circadian gain signal (from the SCN) and the 60–90 minute ultradian pulse generator (from internal feedback).38
4. Implement HPA Kinetics:
    ◦ Feedforward: Model the ACTH $\rightarrow$ Cortisol link using a quantitative Hill function.50
    ◦ Feedback: Model the Cortisol $\dashv$ ACTH/CRH link using the dual-receptor (MR/GR) system.37
5. Parameterize: Use the quantitative values in Table 1 (Melatonin) and Table 2 (HPA) to set model parameters and validation targets.
Tier 2: Modulatory Coupling (The Sleep-Wake Switch)
1. Implement Orexin: Add the Orexin_Activity signal, modeled as a function of sleep-wake state 58, not as a plasma-level simulation.29
2. Couple Orexin-HPA: Link Orexin_Activity as a positive, feedforward input to CRH_Production_Rate.62
3. Implement Sleep Switch: Add the Histamine_Activity variable, inhibited by [Melatonin], to create a mechanistic "sleep-wake switch".66
4. Implement CAR Modulation: Add a Serotonin_Tone variable as a modulator of the CAR pulse amplitude, linking it to stress/mood state.71
Tier 3: Frontier Expansion (Holistic System-of-Systems)
1. Implement Neuro-Immune Axis: Add [IL6] and `` as state variables with their own circadian-driven production rates.78
2. Implement Sickness Loop: Implement the Cytokine $\dashv$ Orexin (fatigue) 59 and Cortisol $\dashv$ Cytokine (anti-inflammatory) 73 feedback loops.
3. Implement Metabolic Model: Add the peripheral Glucose/Insulin subsystem, modeled using Michaelis-Menten kinetics.88
4. Parameterize Metabolism: Use the kinetic constants in Table 3 to parameterize the glucose-insulin model.
5. Simulate Misalignment: Implement Meal_Time as a separate zeitgeber for the metabolic model, distinct from the SCN's Light_Input. This enables the simulation of circadian misalignment, such as shift work and social jet lag.85

Conclusions

This report outlines a comprehensive, staged roadmap to "significantly improve" the provided physiological simulation model. The core recommendation is a fundamental architectural shift: moving away from a descriptive model that replays static physiological rhythms and toward a dynamic, mechanistic model where these rhythms emerge from the interaction of coupled, nonlinear subsystems.
By implementing the Tier 1 recommendations, the model will gain a robust, entrainable core (SCN and HPA axis) based on state-of-the-art quantitative frameworks. The Tier 2 enhancements will connect this core to behavioral state, creating a functional sleep-wake switch and modeling state-dependent reactivity. Finally, the Tier 3 expansion transforms the simulation into a truly holistic "system of systems," capable of modeling the complex, emergent behaviors of the neuro-immune-endocrine network.
This upgraded architecture will provide powerful, predictive capabilities. The simulation will no longer be limited to modeling a "normal" 24-hour day. It will be capable of simulating the body's dynamic, multi-system response to real-world perturbations, including jet lag, acute and chronic stress, shift work, late-night eating, and infection. This emergent behavior is the hallmark of a high-fidelity, next-generation physiological simulation.



[**pmc.ncbi.nlm.nih.gov**Effects of light on human circadian rhythms, sleep and mood - PMC - PubMed CentralOpens in a new window](https://pmc.ncbi.nlm.nih.gov/articles/PMC6751071/)

[**pmc.ncbi.nlm.nih.gov**Synchronization of Biological Clock Neurons by Light and Peripheral Feedback Systems Promotes Circadian Rhythms and Health - PubMed CentralOpens in a new window](https://pmc.ncbi.nlm.nih.gov/articles/PMC4456861/)

[**explorationpub.com**Impact of circadian clock dysfunction on human health - Open Exploration PublishingOpens in a new window](https://www.explorationpub.com/Journals/en/Article/10062)

[**pmc.ncbi.nlm.nih.gov**Genetics of the human circadian clock and sleep homeostat - PMC - PubMed Central - NIHOpens in a new window](https://pmc.ncbi.nlm.nih.gov/articles/PMC6879540/)

[**biorxiv.org**Arginine-Vasopressin Expressing Neurons in the Murine Suprachiasmatic Nucleus Exhibit a Circadian Rhythm in Network Coherence In Vivo | bioRxivOpens in a new window](https://www.biorxiv.org/content/10.1101/2021.12.07.471437.full)

[**pmc.ncbi.nlm.nih.gov**CENTRAL AND PERIPHERAL CIRCADIAN CLOCKS IN MAMMALS - PMCOpens in a new window](https://pmc.ncbi.nlm.nih.gov/articles/PMC3710582/)

[**researchgate.net**A Simpler Model of the Human Circadian Pacemaker | Request PDF - ResearchGateOpens in a new window](https://www.researchgate.net/publication/12670305_A_Simpler_Model_of_the_Human_Circadian_Pacemaker)

[**pubmed.ncbi.nlm.nih.gov**Revised limit cycle oscillator model of human circadian pacemaker - PubMed - NIHOpens in a new window](https://pubmed.ncbi.nlm.nih.gov/10643746/)

[**journals.plos.org**Synchronization-Induced Rhythmicity of Circadian Oscillators in the Suprachiasmatic Nucleus | PLOS Computational Biology - Research journalsOpens in a new window](https://journals.plos.org/ploscompbiol/article?id=10.1371/journal.pcbi.0030068)

[**frontiersin.org**Peripheral clocks and systemic zeitgeber interactions: from molecular mechanisms to circadian precision medicine - FrontiersOpens in a new window](https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2025.1606242/pdf)

[**pmc.ncbi.nlm.nih.gov**The clock shop: Coupled circadian oscillators - PMC - PubMed CentralOpens in a new window](https://pmc.ncbi.nlm.nih.gov/articles/PMC3568450/)

[**frontiersin.org**Circadian rhythm mechanism in the suprachiasmatic nucleus and its relation to the olfactory system - FrontiersOpens in a new window](https://www.frontiersin.org/journals/neural-circuits/articles/10.3389/fncir.2024.1385908/full)

[**pubmed.ncbi.nlm.nih.gov**Melatonin and human rhythms - PubMedOpens in a new window](https://pubmed.ncbi.nlm.nih.gov/16687277/)

[**experiments.springernature.com**Mathematical Modeling of Circadian Rhythms | Springer Nature ExperimentsOpens in a new window](https://experiments.springernature.com/articles/10.1007/978-1-0716-2577-4_19)

[**pmc.ncbi.nlm.nih.gov**Mathematical modeling of circadian rhythms - PMC - PubMed Central - NIHOpens in a new window](https://pmc.ncbi.nlm.nih.gov/articles/PMC6375788/)

[**pmc.ncbi.nlm.nih.gov**The circadian stimulus-oscillator model: Improvements to Kronauer's model of the human circadian pacemaker - PMC - PubMed CentralOpens in a new window](https://pmc.ncbi.nlm.nih.gov/articles/PMC9552883/)

[**pmc.ncbi.nlm.nih.gov**Daily Light Exposure Patterns Reveal Phase and Period of the Human Circadian ClockOpens in a new window](https://pmc.ncbi.nlm.nih.gov/articles/PMC5476188/)

[**frontiersin.org**A Mathematical Model to Characterize the Role of Light Adaptation in Mammalian Circadian Clock - FrontiersOpens in a new window](https://www.frontiersin.org/journals/molecular-biosciences/articles/10.3389/fmolb.2021.681696/full)

[**jneurosci.org**A Mathematical Model for the Intracellular Circadian Rhythm GeneratorOpens in a new window](https://www.jneurosci.org/content/19/1/40)

[**sites.ecse.rpi.edu**Light-based circadian rhythm control: Entrainment and optimization - RPI ECSEOpens in a new window](https://sites.ecse.rpi.edu/~agung/Research/Zhang_Automatica.pdf)

[**pubmed.ncbi.nlm.nih.gov**Application of a Limit-Cycle Oscillator Model for Prediction of Circadian Phase in Rotating Night Shift Workers - PubMedOpens in a new window](https://pubmed.ncbi.nlm.nih.gov/31363110/)

[**pnas.org**Sex difference in the near-24-hour intrinsic period of the human circadian timing systemOpens in a new window](https://www.pnas.org/doi/10.1073/pnas.1010666108)

[**pmc.ncbi.nlm.nih.gov**Melatonin: Pharmacology, Functions and Therapeutic Benefits - PMC - PubMed CentralOpens in a new window](https://pmc.ncbi.nlm.nih.gov/articles/PMC5405617/)

[**pubmed.ncbi.nlm.nih.gov**Clinical pharmacokinetics of melatonin: a systematic review - PubMedOpens in a new window](https://pubmed.ncbi.nlm.nih.gov/26008214/)

[**pubmed.ncbi.nlm.nih.gov**A Randomized, Double-Blind, Crossover Study to Investigate the Pharmacokinetics of Extended-Release Melatonin Compared to Immediate-Release Melatonin in Healthy Adults - PubMedOpens in a new window](https://pubmed.ncbi.nlm.nih.gov/37150895/)

[**stacks.cdc.gov**Calculating the Dim Light Melatonin Onset: The Impact ... - CDC StacksOpens in a new window](https://stacks.cdc.gov/view/cdc/193223/cdc_193223_DS1.pdf)

[**tandfonline.com**Full article: A comparison of four methods to estimate dim light melatonin onset: a repeatability and agreement studyOpens in a new window](https://www.tandfonline.com/doi/full/10.1080/07420528.2022.2150554)

[**salimetrics.com**Shift Right: Assessing Circadian Rhythm Sleep Disorders and Associated Health Concerns Based on Salivary Melatonin and Dim Light Melatonin Onset (DLMO) - SalimetricsOpens in a new window](https://salimetrics.com/salivary-melatonin-and-dim-light-melatonin-onset-dlmo/)

[**pmc.ncbi.nlm.nih.gov**Plasma Orexin-A Levels Do Not Undergo Circadian Rhythm in ...Opens in a new window](https://pmc.ncbi.nlm.nih.gov/articles/PMC6289979/)

[**pubmed.ncbi.nlm.nih.gov**Pharmacokinetics of Melatonin in Human Sexual Maturation - PubMed - NIHOpens in a new window](https://pubmed.ncbi.nlm.nih.gov/8626852/)

[**my.clevelandclinic.org**Hypothalamic-Pituitary-Adrenal (HPA) Axis: What It Is - Cleveland ClinicOpens in a new window](https://my.clevelandclinic.org/health/body/hypothalamic-pituitary-adrenal-hpa-axis)

[**tandfonline.com**Role of glucocorticoid negative feedback in the regulation of HPA axis pulsatilityOpens in a new window](https://www.tandfonline.com/doi/full/10.1080/10253890.2018.1470238)

[**pmc.ncbi.nlm.nih.gov**A Review of Hypothalamic-Pituitary-Adrenal Axis Function in Chronic Fatigue SyndromeOpens in a new window](https://pmc.ncbi.nlm.nih.gov/articles/PMC4045534/)

[**pmc.ncbi.nlm.nih.gov**Modeling the hypothalamus-pituitary-adrenal axis: A review and extension - PMCOpens in a new window](https://pmc.ncbi.nlm.nih.gov/articles/PMC4568136/)

[**academic.oup.com**Dynamics of ACTH and Cortisol Secretion and Implications for Disease - Oxford AcademicOpens in a new window](https://academic.oup.com/edrv/article/41/3/bnaa002/5736359)

[**ncbi.nlm.nih.gov**Physiology, Adrenocorticotropic Hormone (ACTH) - StatPearls - NCBI Bookshelf - NIHOpens in a new window](https://www.ncbi.nlm.nih.gov/books/NBK500031/)

[**pmc.ncbi.nlm.nih.gov**Dynamics of ACTH and Cortisol Secretion and Implications for Disease - PMCOpens in a new window](https://pmc.ncbi.nlm.nih.gov/articles/PMC7240781/)

[**pmc.ncbi.nlm.nih.gov**Sleep and Circadian Regulation of Cortisol: A Short Review - PMC - PubMed CentralOpens in a new window](https://pmc.ncbi.nlm.nih.gov/articles/PMC8813037/)

[**pmc.ncbi.nlm.nih.gov**Circadian rhythms and the HPA axis: A systems view - PMC - PubMed CentralOpens in a new window](https://pmc.ncbi.nlm.nih.gov/articles/PMC8900069/)

[**mdpi.com**Cortisol on Circadian Rhythm and Its Effect on Cardiovascular System - MDPIOpens in a new window](https://www.mdpi.com/1660-4601/18/2/676)

[**pmc.ncbi.nlm.nih.gov**The Functional and Clinical Significance of the 24-Hour Rhythm of Circulating Glucocorticoids - PMC - PubMed CentralOpens in a new window](https://pmc.ncbi.nlm.nih.gov/articles/PMC5563520/)

[**academic.oup.com**Functional and Clinical Significance of the 24-Hour Rhythm of ...Opens in a new window](https://academic.oup.com/edrv/article/38/1/3/2959892)

[**pmc.ncbi.nlm.nih.gov**Fast dynamics in the HPA axis: Insight from mathematical and experimental studies - PMCOpens in a new window](https://pmc.ncbi.nlm.nih.gov/articles/PMC9823091/)

[**frontiersin.org**The circadian system modulates the cortisol awakening response in humans - FrontiersOpens in a new window](https://www.frontiersin.org/journals/neuroscience/articles/10.3389/fnins.2022.995452/full)

[**pmc.ncbi.nlm.nih.gov**Circadian Clock Control of Endocrine Factors - PMC - PubMed CentralOpens in a new window](https://pmc.ncbi.nlm.nih.gov/articles/PMC4304769/)

[**ncbi.nlm.nih.gov**Pharmacokinetics of Corticosteroids - Holland-Frei Cancer Medicine - NCBI Bookshelf - NIHOpens in a new window](https://www.ncbi.nlm.nih.gov/books/NBK13300/)

[**pmc.ncbi.nlm.nih.gov**Quantifying Pituitary-Adrenal Dynamics and Deconvolution of Concurrent Cortisol and Adrenocorticotropic Hormone Data by Compressed Sensing - PMC - NIHOpens in a new window](https://pmc.ncbi.nlm.nih.gov/articles/PMC4579049/)

[**pubmed.ncbi.nlm.nih.gov**Pharmacokinetics, Cortisol Release, and Hemodynamics After Intravenous and Subcutaneous Injection of Human Corticotropin-Releasing Factor in Humans - PubMedOpens in a new window](https://pubmed.ncbi.nlm.nih.gov/9834042/)

[**academic.oup.com**Tripartite Control of Dynamic ACTH-Cortisol Dose Responsiveness by Age, Body Mass Index, and Gender in 111 Healthy Adults | The Journal of Clinical Endocrinology & Metabolism | Oxford AcademicOpens in a new window](https://academic.oup.com/jcem/article/96/9/2874/2834681)

[**researchgate.net**Dose-response curves of the plasma ACTH concentration and cortisol... - ResearchGateOpens in a new window](https://www.researchgate.net/figure/Dose-response-curves-of-the-plasma-ACTH-concentration-and-cortisol-secretion-rate-in-30_fig1_51643335)

[**pmc.ncbi.nlm.nih.gov**A more holistic view of the logarithmic dose–response curve offers greater insights into insulin responses - PubMed CentralOpens in a new window](https://pmc.ncbi.nlm.nih.gov/articles/PMC11731574/)

[**pmc.ncbi.nlm.nih.gov**Predicting the Activation of the Androgen Receptor by Mixtures of Ligands Using Generalized Concentration Addition - NIHOpens in a new window](https://pmc.ncbi.nlm.nih.gov/articles/PMC7548291/)

[**pmc.ncbi.nlm.nih.gov**To modulate or to skip: De-escalating PARP inhibitor maintenance therapy in ovarian cancer using adaptive therapy - NIHOpens in a new window](https://pmc.ncbi.nlm.nih.gov/articles/PMC11190943/)

[**pmc.ncbi.nlm.nih.gov**A glucose-insulin-glucagon coupled model of the isoglycemic intravenous glucose infusion experiment - PMC - NIHOpens in a new window](https://pmc.ncbi.nlm.nih.gov/articles/PMC9485803/)

[**pmc.ncbi.nlm.nih.gov**Dose-response downregulation within the span of single interpulse intervals - PMC - NIHOpens in a new window](https://pmc.ncbi.nlm.nih.gov/articles/PMC2904156/)

[**journals.physiology.org**The principle of homeostasis in the hypothalamus-pituitary-adrenal system: new insight from positive feedback - American Physiological Society JournalOpens in a new window](https://journals.physiology.org/doi/abs/10.1152/ajpregu.00907.2006)

[**pmc.ncbi.nlm.nih.gov**Sleep, circadian rhythms and health - PMC - PubMed CentralOpens in a new window](https://pmc.ncbi.nlm.nih.gov/articles/PMC7202392/)

[**pmc.ncbi.nlm.nih.gov**Daily Fluctuation of Orexin Neuron Activity and Wiring: The ...Opens in a new window](https://pmc.ncbi.nlm.nih.gov/articles/PMC6167434/)

[**explorationpub.com**An integrative review on the orexin system and hypothalamic dysfunction in myalgic encephalomyelitis/chronic fatigue syndrome: implications for precision medicine - Open Exploration PublishingOpens in a new window](https://www.explorationpub.com/Journals/ent/Article/1004112)

[**pmc.ncbi.nlm.nih.gov**The hypocretins/orexins: integrators of multiple physiological functions - PMCOpens in a new window](https://pmc.ncbi.nlm.nih.gov/articles/PMC3904255/)

[**pubmed.ncbi.nlm.nih.gov**Orexins in the Regulation of the Hypothalamic-Pituitary-Adrenal Axis - PubMedOpens in a new window](https://pubmed.ncbi.nlm.nih.gov/16507882/)

[**pmc.ncbi.nlm.nih.gov**Orexins and stress - PMC - PubMed CentralOpens in a new window](https://pmc.ncbi.nlm.nih.gov/articles/PMC6345253/)

[**repository.brynmawr.edu**Orexin 2 receptor regulation of the hypothalamic–pituitary–adrenal (HPA) response to acute and repeated stressOpens in a new window](https://repository.brynmawr.edu/cgi/viewcontent.cgi?article=1072&context=psych_pubs)

[**mdpi.com**The Orexin/Hypocretin System, the Peptidergic Regulator of Vigilance, Orchestrates Adaptation to Stress - MDPIOpens in a new window](https://www.mdpi.com/2227-9059/12/2/448)

[**pmc.ncbi.nlm.nih.gov**OREXIN 2 RECEPTOR REGULATION OF THE HYPOTHALAMIC–PITUITARY–ADRENAL (HPA) RESPONSE TO ACUTE AND REPEATED STRESS - PMC - PubMed CentralOpens in a new window](https://pmc.ncbi.nlm.nih.gov/articles/PMC6322837/)

[**pmc.ncbi.nlm.nih.gov**The interplay between mast cells, pineal gland, and circadian rhythm: Links between histamine, melatonin, and inflammatory mediators - PMC - PubMed CentralOpens in a new window](https://pmc.ncbi.nlm.nih.gov/articles/PMC9275476/)

[**pmc.ncbi.nlm.nih.gov**Sites of Action of Sleep and Wake Drugs: Insights from Model Organisms - PMCOpens in a new window](https://pmc.ncbi.nlm.nih.gov/articles/PMC3783591/)

[**pmc.ncbi.nlm.nih.gov**Research progress on melatonin, 5-HT, and orexin in sleep disorders of children with autism spectrum disorder - PMC - PubMed CentralOpens in a new window](https://pmc.ncbi.nlm.nih.gov/articles/PMC12010984/)

[**pmc.ncbi.nlm.nih.gov**Understanding the relationships between physiological and psychosocial stress, cortisol and cognition - PMC - PubMed CentralOpens in a new window](https://pmc.ncbi.nlm.nih.gov/articles/PMC10025564/)

[**journals.physiology.org**Physiology and Neurobiology of Stress and Adaptation: Central Role of the BrainOpens in a new window](https://journals.physiology.org/doi/full/10.1152/physrev.00041.2006)

[**pmc.ncbi.nlm.nih.gov**Stress Hormone Dynamics Are Coupled to Brain Serotonin 4 Receptor Availability in Unmedicated Patients With Major Depressive Disorder: A NeuroPharm Study - PMC - PubMed CentralOpens in a new window](https://pmc.ncbi.nlm.nih.gov/articles/PMC10519814/)

[**pmc.ncbi.nlm.nih.gov**Neuroendocrine-Immune Circuits, Phenotypes, and Interactions - PMC - PubMed CentralOpens in a new window](https://pmc.ncbi.nlm.nih.gov/articles/PMC5203943/)

[**pmc.ncbi.nlm.nih.gov**Neuroendocrine Interactions in the Immune System - PMC - PubMed CentralOpens in a new window](https://pmc.ncbi.nlm.nih.gov/articles/PMC2562609/)

[**pmc.ncbi.nlm.nih.gov**Neuro-Endocrine Networks Controlling Immune System in Health and Disease - PMCOpens in a new window](https://pmc.ncbi.nlm.nih.gov/articles/PMC3985001/)

[**pmc.ncbi.nlm.nih.gov**Editorial: Beyond the borders: The gates and fences of neuroimmune interaction, volume IIOpens in a new window](https://pmc.ncbi.nlm.nih.gov/articles/PMC9379303/)

[**pmc.ncbi.nlm.nih.gov**Immune and Nervous Systems Interaction in Endocrine Disruptors Toxicity: The Case of Atrazine - PMC - PubMed CentralOpens in a new window](https://pmc.ncbi.nlm.nih.gov/articles/PMC8915797/)

[**pubmed.ncbi.nlm.nih.gov**IL-6 and its circadian secretion in humans - PubMedOpens in a new window](https://pubmed.ncbi.nlm.nih.gov/15905620/)

[**pubmed.ncbi.nlm.nih.gov**Circadian characteristics of circulating interleukin-6 in men - PubMedOpens in a new window](https://pubmed.ncbi.nlm.nih.gov/7751499/)

[**pubmed.ncbi.nlm.nih.gov**Circadian rhythmicity, variability and correlation of interleukin-6 levels in plasma and cerebrospinal fluid of healthy men - PubMedOpens in a new window](https://pubmed.ncbi.nlm.nih.gov/24767621/)

[**pubmed.ncbi.nlm.nih.gov**Circadian interleukin-6 secretion and quantity and depth of sleep - PubMedOpens in a new window](https://pubmed.ncbi.nlm.nih.gov/10443646/)

[**pubmed.ncbi.nlm.nih.gov**The regulation of circadian clock by tumor necrosis factor alpha - PubMedOpens in a new window](https://pubmed.ncbi.nlm.nih.gov/31000463/)

[**pubmed.ncbi.nlm.nih.gov**TNF-α induces expression of the circadian clock gene Bmal1 via dual calcium-dependent pathways in rheumatoid synovial cells - PubMedOpens in a new window](https://pubmed.ncbi.nlm.nih.gov/29217191/)

[**pmc.ncbi.nlm.nih.gov**The reciprocal interplay between TNFα and the circadian clock impacts on cell proliferation and migration in Hodgkin lymphoma cellsOpens in a new window](https://pmc.ncbi.nlm.nih.gov/articles/PMC6068144/)

[**pmc.ncbi.nlm.nih.gov**Mathematical modeling of mammalian circadian clocks affecting drug and disease responses - PMC - PubMed CentralOpens in a new window](https://pmc.ncbi.nlm.nih.gov/articles/PMC8855863/)

[**royalsocietypublishing.org**Cycle dynamics and synchronization in a coupled network of peripheral circadian clocksOpens in a new window](https://royalsocietypublishing.org/doi/10.1098/rsfs.2021.0087)

[**pmc.ncbi.nlm.nih.gov**Circadian system and glucose metabolism: implications for physiology and disease - PMCOpens in a new window](https://pmc.ncbi.nlm.nih.gov/articles/PMC4842150/)

[**e-dmj.org**Attention to Innate Circadian Rhythm and the Impact of Its Disruption on DiabetesOpens in a new window](https://e-dmj.org/journal/view.php?number=2787)

[**pubmed.ncbi.nlm.nih.gov**Insulin increases the maximum velocity for glucose uptake without altering the Michaelis constant in man. Evidence that insulin increases glucose uptake merely by providing additional transport sites - PubMedOpens in a new window](https://pubmed.ncbi.nlm.nih.gov/6757268/)

[**pmc.ncbi.nlm.nih.gov**Insulin increases the maximum velocity for glucose uptake without altering the Michaelis constant in man. Evidence that insulin increases glucose uptake merely by providing additional transport sites - NIHOpens in a new window](https://pmc.ncbi.nlm.nih.gov/articles/PMC370349/)

[**pubmed.ncbi.nlm.nih.gov**Estimation and kinetic analysis of insulin-independent glucose uptake in human subjects - PubMedOpens in a new window](https://pubmed.ncbi.nlm.nih.gov/6344653/)

[**pmc.ncbi.nlm.nih.gov**Physiologically Based Pharmacokinetic Modeling and Simulation in Regulatory Review: US FDA CBER Experience and Perspectives - NIHOpens in a new window](https://pmc.ncbi.nlm.nih.gov/articles/PMC12541349/)

[**pmc.ncbi.nlm.nih.gov**Application of Pharmacokinetic-Pharmacodynamic Modeling in Drug Delivery: Development and Challenges - PMC - PubMed CentralOpens in a new window](https://pmc.ncbi.nlm.nih.gov/articles/PMC7348046/)

[**tandfonline.com**Full article: Mechanistic PK/PD modeling to address early-stage biotherapeutic dosing feasibility questionsOpens in a new window](https://www.tandfonline.com/doi/full/10.1080/19420862.2023.2192251)

[**pmc.ncbi.nlm.nih.gov**Development of Translational Pharmacokinetic–Pharmacodynamic Models - PMC - NIHOpens in a new window](https://pmc.ncbi.nlm.nih.gov/articles/PMC2671003/)

[**pmc.ncbi.nlm.nih.gov**A Novel Strategy to Fit and Validate Physiological Models: A Case Study of a Cardiorespiratory Model for Simulation of Incremental Aerobic Exercise - PubMed CentralOpens in a new window](https://pmc.ncbi.nlm.nih.gov/articles/PMC10000473/)

[**mdpi.com**A Public Dataset of 24-h Multi-Levels Psycho-Physiological ... - MDPIOpens in a new window](https://www.mdpi.com/2306-5729/5/4/91)

[**physionet.org**Databases - PhysioNetOpens in a new window](https://www.physionet.org/about/database/)

[**pmc.ncbi.nlm.nih.gov**Investigating sources of inaccuracy in wearable optical heart rate sensors - PMC - NIHOpens in a new window](https://pmc.ncbi.nlm.nih.gov/articles/PMC7010823/)

[**pmc.ncbi.nlm.nih.gov**Association of Blood Glucose Data With Physiological and Nutritional Data From Dietary Surveys and Wearable Devices: Database Analysis - NIHOpens in a new window](https://pmc.ncbi.nlm.nih.gov/articles/PMC11653050/)

[**mdpi.com**Wearable Solutions Using Physiological Signals for Stress Monitoring on Individuals with Autism Spectrum Disorder (ASD): A Systematic Literature Review - MDPIOpens in a new window](https://www.mdpi.com/1424-8220/24/24/8137)

[**escholarship.org**Efficient Digital Health Solutions Using Wearable Devices - eScholarshipOpens in a new window](https://escholarship.org/content/qt1fp76657/qt1fp76657.pdf)

[**wwwn.cdc.gov**NHANES Tutorials - Datasets and Documentation Module - CDCOpens in a new window](https://wwwn.cdc.gov/nchs/nhanes/tutorials/datasets.aspx)

[**pmc.ncbi.nlm.nih.gov**Harmonized US National Health and Nutrition Examination Survey 1988-2018 for high throughput exposome-health discovery - NIHOpens in a new window](https://pmc.ncbi.nlm.nih.gov/articles/PMC9934713/)

[**wwwn.cdc.gov**Laboratory Data - Continuous NHANES - CDCOpens in a new window](https://wwwn.cdc.gov/nchs/nhanes/search/datapage.aspx?Component=Laboratory)

[**journals.plos.org**Association of probiotic ingestion with serum sex steroid hormones among pre- and postmenopausal women](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0294436)